Fragile X syndrome type 3
News & Events
On this page
ORDR Co-Sponsored Conferences
2016 Rare Disease Day at NIH, Monday, February 29, 2016
Location: Building 10, Masur Auditorium, National Institutes of Health, Bethesda, MD
Description: The 2016 Rare Disease Day at NIH will take place on February 29. The event, sponsored by NCATS and the NIH Clinical Center, aims to raise awareness about rare diseases, the patients they affect and the research collaborations that are addressing rare disease challenges. The day will feature tours, posters and exhibits, and presentations.
Neural Interfaces Conference 2010 , Monday, June 21, 2010 - Tuesday, June 22, 2010
Location: Long Beach Convention Center, Long Beach, California
Description: The goal of the workshop was to present state-of-the-art technological advances to both the neural prosthesis and deep brain stimulation (DBS) communities while encouraging interaction between these two groups to develop new collaborations to create therapies for human use. In addition, inclusion and showcasing of trainees was an important goal. Student poster presentations fostered scientific exchange, networking, and communication among registrants and 20 travel awards were given to qualifying undergraduate, graduate or medical students, and postdoctoral fellows. One such interaction between student and principal investigator (PI) has resulted in the student becoming a postdoctoral fellow in the PI’s laboratory.
Interdisciplinary Training Conference in Developmental Disabilities, Monday, March 15, 2010 - Tuesday, March 16, 2010
Location: Annapolis, Maryland
Description: The goal of this meeting was to mentor the career development of a “hybrid” junior scientist working in developmental disabilities research, including those within T32 training programs as well as other training programs. The focus was on pre- and postdoctoral students (scholars-in-training) because interdisciplinary training after scientific formation appears to be less effective in nurturing biobehavioral scientists with an integrated focus.
Outcome Measures for Clinical Trials in Children with Fragile X Syndrome – Part II, Thursday, November 05, 2009 - Friday, November 06, 2009
Location: Bethesda Marriott Pooks Hill, Bethesda, MD
Description: The goals of the first meeting were to (1) describe outcome measures for safety and efficacy when treating children with FXS, (2) assess validation of those measures for clinical studies, and (3) describe approaches for preclinical toxicology studies to define efficacy and safety.
Workshop on Reproduction and the Fragile X Premutation, Wednesday, April 13, 2005 - Friday, April 15, 2005
Location: William F. Bolger Center, Potomac, MD
Description: Workshop goals were to examine the basic science and clinical and epidemiological evidence regarding the fragile X premutation and its effects on reproduction.